Evolutionary tracks for Betelgeuse

We have constructed a series of non-rotating quasi-hydrostatic evolutionary models for the M2 Iab supergiant Betelgeuse ($\alpha~Orionis$). Our models are constrained by multiple observed values for the temperature, luminosity, surface composition and mass loss for this star, along with the parallax distance and high resolution imagery that determines its radius. We have then applied our best-fit models to analyze the observed variations in surface luminosity and the size of detected surface bright spots as the result of up-flowing convective material from regions of high temperature in the surface convective zone. We also attempt to explain the intermittently observed periodic variability in a simple radial linear adiabatic pulsation model. Based upon the best fit to all observed data, we suggest a best progenitor mass estimate of $20 ^{+5}_{-3} M_\odot$ and a current age from the start of the zero-age main sequence of $8.0 - 8.5$ Myr based upon the observed ejected mass while on the giant branch.Comment: 27 pages, 11 figures, Revised per referee suggestions, Accepted for publication in the Astrophysical Journa

Young and old genetically heterogeneous HET3 mice on a rapamycin diet are glucose intolerant but insulin sensitive

Rapamycin, an inhibitor of the mechanistic target of rapamycin (mTOR) signaling pathway, extends the life span of yeast, worms, flies, and mice. Interventions that promote longevity are often correlated with increased insulin sensitivity, and it therefore is surprising that chronic rapamycin treatment of mice, rats, and humans is associated with insulin resistance (J Am Soc Nephrol., 19, 2008, 1411; Diabetes, 00, 2010, 00; Science, 335, 2012, 1638). We examined the effect of dietary rapamycin treatment on glucose homeostasis and insulin resistance in the genetically heterogeneous HET3 mouse strain, a strain in which dietary rapamycin robustly extends mean and maximum life span. We find that rapamycin treatment leads to glucose intolerance in both young and old HET3 mice, but in contrast to the previously reported effect of injected rapamycin in C57BL/6 mice, HET3 mice treated with dietary rapamycin responded normally in an insulin tolerance test. To gauge the overall consequences of rapamycin treatment on average blood glucose levels, we measured HBA1c. Dietary rapamycin increased HBA1c over the first 3 weeks of treatment in young animals, but the effect was lost by 3 months, and no effect was detected in older animals. Our results demonstrate that the extended life span of HET3 mice on a rapamycin diet occurs in the absence of major changes in insulin sensitivity and highlight the importance of strain background and delivery method in testing effects of longevity interventions.National Institutes of Health (U.S.)National Institute on Aging (Grant AG 035860)National Institute on Aging (Grant AG 022308)National Cancer Institute (U.S.) (Grant CA 129105)American Federation for Aging Research (Julie Martin Mid-Career Award in Aging Research)National Institutes of Health (U.S.) (National Institute on Aging K00/R00 Award 1K99AG041765-01A1

Identification and characterization of an irreversible inhibitor of CDK2

Irreversible inhibitors that modify cysteine or lysine residues within a protein kinase ATP binding site offer, through their distinctive mode of action, an alternative to ATP-competitive agents. 4-((6-(Cyclohexylmethoxy)- 9H-purin-2-yl)amino)benzenesulfonamide (NU6102) is a potent and selective ATP-competitive inhibitor of CDK2 in which the sulfonamide moiety is positioned close to a pair of lysine residues. Guided by the CDK2/NU6102 structure, we designed 6-(cyclohexylmethoxy)-N-(4-(vinylsulfonyl)phenyl)-9H-purin-2-amine (NU6300), which binds covalently to CDK2 as shown by a co-complex crystal structure. Acute incubation with NU6300 produced a durable inhibition of Rb phosphorylation in SKUT-1B cells, consistent with it acting as an irreversible CDK2 inhibitor. NU6300 is the first covalent CDK2 inhibitor to be described, and illustrates the potential of vinyl sulfones for the design of more potent and selective compounds

The effect of the cyclin D1 (CCND1) A870G polymorphism on colorectal cancer risk is modified by glutathione-S-transferase polymorphisms and isothiocyanate intake in the Singapore Chinese Health Study

Cyclin D1 (CCND1) regulates cellular decision between proliferation and growth arrest. Despite the functional relevance of the CCND1 A870G single nucleotide polymorphism (SNP) published results on its association with colorectal cancer (CRC) were inconsistent. We examined the association between this CCND1 genotype and CRC in the Singapore Chinese Health Study, a prospective investigation of diet and cancer in 63 000 Chinese men and women. We explored the hypothesis that inconsistency regarding the CCND1/CRC association may be attributable to the modifying effect of additional CRC risk factors. Since GSTM1/GSTT1 genotype and dietary isothiocyanate (ITC) intake had previously been identified as CRC risk factors in this cohort, we now explored if they influenced the CCND1/CRC association. In a nested case-control study within the Singapore Cohort, genomic DNA collected from 300 incident CRC cases and 1169 controls was examined for CCND1, GSTM1, GSTT1 and GSTP1 polymorphisms. Unconditional logistic regression was used to assess genotype effects on cancer risk. No main effect of CCND1 was observed, yet the CCND1 effect was influenced by ITC intake and GST genotypes. The presence of at least one CCND1 A-allele was associated with increased risk among low dietary ITC consumers (intake below median value for the cohort) with a high-activity GST profile (≥2 of the 3 GST genotypes classified non-null or high-activity) [odds ratio (OR) = 2.05; 95% confidence interval (CI), 1.10-3.82]. In contrast, the presence of at least one A-allele was associated with a decreased risk among all remaining subjects (OR = 0.56; 0.36-0.86) (P for interaction = 0.01). Recent studies indicate that ITCs inhibit cell proliferation and cause apoptosis through pro-oxidant properties. The results of our current study on CRC and those of our previous breast cancer study are compatible with the notion of oxidative stress in target cells as important determinant of direction and magnitude of the CCND1 effec

Bi Alloying into Rare Earth Double Perovskites Enhances Synthesizability and Visible Light Absorption

A high throughput combinatorial synthesis utilizing inkjet printing of precursor inks was used to rapidly evaluate Bi-alloying into double perovskite oxides for enhanced visible light absorption. The fast visual screening of photo image scans of the library plates identifies 4-metal oxide compositions displaying an increase in light absorption, which subsequent UV–vis spectroscopy indicates is due to bandgap reduction. Structural characterization by X-ray diffraction (XRD) and Raman spectroscopy demonstrates that the visually darker composition range contains Bi-alloyed Sm₂MnNiO₆ (double perovskite structure), of the form (Bi,Sm)₂MnNiO₆. Bi alloying not only increases the visible absorption but also facilitates crystallization of this structure at the relatively low annealing temperature of 615 °C. Investigation of additional seven combinations of a rare earth (RE) and a transition metal (TM) with Bi and Mn indicates that Bi-alloying on the RE site occurs with similar effect in the family of rare earth oxide double perovskites

Enhanced Bulk Transport in Copper Vanadate Photoanodes Identified by Combinatorial Alloying

The impact of alloying on the performance of β-Cu₂V₂O₇ photoanodes was investigated using inkjet printing of composition libraries containing 1,809 Cu₂V₂O₇-based photoanodes. Six elements (Zr, Ca, Hf, Gd, La, and Lu) were alloyed and pairwise co-alloyed at concentrations up to 7 at % into Cu-rich, stoichiometric, and Cu-deficient host Cu₂V₂O₇. A 1.7-fold increase in oxygen evolution photocurrent in pH 9.2 electrolyte was obtained by alloying Ca into β-Cu₂V₂O₇. Experiments employing a hole scavenger to better characterize bulk charge separation and transport revealed a 2.2-fold increase in photoactivity via alloying with Hf, Zr, and La, which increased to 2.7-fold upon co-alloying these elements with Ca. Concurrent with increased photoactivity is substantially decreased photon absorption between 1.5 and 2 eV, a range reported to coincide with high exciton absorption in β-Cu₂V₂O₇, motivating further exploration of whether these co-alloy compositions may destabilize the excitonic state that appears to have limited performance to date